The drug-to-antibody ratio(DAR) is a critical quality attribute of antibody-drug conjugates(ADCs),directly affecting their efficacy, safety, and pharmacokinetic properties. This review systematically summarizes the analytical methods for DAR determination and optimization strategies for homogeneous ADCs. Current detection technologies include hydrophobic interaction chromatography, reversed-phase high-performance liquid chromatography, mass spectrometry,ultraviolet-visible spectroscopy, and emerging multi-dimensional liquid chromatography hyphenated techniques. In terms of homogeneity optimization, engineered site-specific conjugation approaches(e.g., THIOMAB, enzymatic conjugation)enable precise control of DAR. Hydrophilic modification of linkers and optimization of payload structure help improve drug loading while maintaining antibody stability. The optimal DAR should be determined by comprehensively considering target expression levels, tumor heterogeneity, and payload properties. This review provides references for ADC process development and quality control.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |